Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.

Cegielski JP, Kurbatova E, van der Walt M, Brand J, Ershova J, Tupasi T, Caoili JC, Dalton T, Contreras C, Yagui M, Bayona J, Kvasnovsky C, Leimane V, Kuksa L, Chen MP, Via LE, Hwang SH, Wolfgang M, Volchenkov GV, Somova T, Smith SE, Akksilp S, Wattanaamornkiet W, Kim HJ, Kim CK, Kazennyy BY, Khorosheva T, Kliiman K, Viiklepp P, Jou R, Huang AS, Vasilyeva IA, Demikhova OV; Global PETTS Investigators, Lancaster J, Odendaal R, Diem L, Perez TC, Gler T, Tan K, Bonilla C, Jave O, Asencios L, Yale G, Suarez C, Walker AT, Norvaisha I, Skenders G, Sture I, Riekstina V, Cirule A, Sigman E, Cho SN, Cai Y, Eum S, Lee J, Park S, Jeon D, Shamputa IC, Metchock B, Kuznetsova T, Akksilp R, Sitti W, Inyapong J, Kiryanova EV, Degtyareva I, Nemtsova ES, Levina K, Danilovits M, Kummik T, Lei YC, Huang WL, Erokhin VV, Chernousova LN, Andreevskaya SN, Larionova EE, Smirnova TG.

Clin Infect Dis. 2016 Feb 15;62(4):418-430. doi: 10.1093/cid/civ910. Epub 2015 Oct 27.

2.

Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage.

Merker M, Blin C, Mona S, Duforet-Frebourg N, Lecher S, Willery E, Blum MG, Rüsch-Gerdes S, Mokrousov I, Aleksic E, Allix-Béguec C, Antierens A, Augustynowicz-Kopeć E, Ballif M, Barletta F, Beck HP, Barry CE 3rd, Bonnet M, Borroni E, Campos-Herrero I, Cirillo D, Cox H, Crowe S, Crudu V, Diel R, Drobniewski F, Fauville-Dufaux M, Gagneux S, Ghebremichael S, Hanekom M, Hoffner S, Jiao WW, Kalon S, Kohl TA, Kontsevaya I, Lillebæk T, Maeda S, Nikolayevskyy V, Rasmussen M, Rastogi N, Samper S, Sanchez-Padilla E, Savic B, Shamputa IC, Shen A, Sng LH, Stakenas P, Toit K, Varaine F, Vukovic D, Wahl C, Warren R, Supply P, Niemann S, Wirth T.

Nat Genet. 2015 Mar;47(3):242-9. doi: 10.1038/ng.3195. Epub 2015 Jan 19.

PMID:
25599400
3.

Isolation and molecular characterization of Mycobacterium tuberculosis from humans and cattle in Namwala District, Zambia.

Malama S, Muma J, Munyeme M, Mbulo G, Muwonge A, Shamputa IC, Djønne B, Godfroid J, Johansen TB.

Ecohealth. 2014 Dec;11(4):564-70. doi: 10.1007/s10393-014-0940-0. Epub 2014 May 21.

PMID:
24845573
4.

Fitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the β' subunit of RNA polymerase.

Song T, Park Y, Shamputa IC, Seo S, Lee SY, Jeon HS, Choi H, Lee M, Glynne RJ, Barnes SW, Walker JR, Batalov S, Yusim K, Feng S, Tung CS, Theiler J, Via LE, Boshoff HI, Murakami KS, Korber B, Barry CE 3rd, Cho SN.

Mol Microbiol. 2014 Mar;91(6):1106-19. doi: 10.1111/mmi.12520. Epub 2014 Feb 26.

5.

Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.

Cho E, Shamputa IC, Kwak HK, Lee J, Lee M, Hwang S, Jeon D, Kim CT, Cho S, Via LE, Barry CE 3rd, Lee JS.

BMC Infect Dis. 2013 Oct 15;13:478. doi: 10.1186/1471-2334-13-478.

6.

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.

Dalton T, Cegielski P, Akksilp S, Asencios L, Campos Caoili J, Cho SN, Erokhin VV, Ershova J, Gler MT, Kazennyy BY, Kim HJ, Kliiman K, Kurbatova E, Kvasnovsky C, Leimane V, van der Walt M, Via LE, Volchenkov GV, Yagui MA, Kang H; Global PETTS Investigators, Akksilp R, Sitti W, Wattanaamornkiet W, Andreevskaya SN, Chernousova LN, Demikhova OV, Larionova EE, Smirnova TG, Vasilieva IA, Vorobyeva AV, Barry CE 3rd, Cai Y, Shamputa IC, Bayona J, Contreras C, Bonilla C, Jave O, Brand J, Lancaster J, Odendaal R, Chen MP, Diem L, Metchock B, Tan K, Taylor A, Wolfgang M, Cho E, Eum SY, Kwak HK, Lee J, Lee J, Min S, Degtyareva I, Nemtsova ES, Khorosheva T, Kyryanova EV, Egos G, Perez MT, Tupasi T, Hwang SH, Kim CK, Kim SY, Lee HJ, Kuksa L, Norvaisha I, Skenders G, Sture I, Kummik T, Kuznetsova T, Somova T, Levina K, Pariona G, Yale G, Suarez C, Valencia E, Viiklepp P.

Lancet. 2012 Oct 20;380(9851):1406-17. doi: 10.1016/S0140-6736(12)60734-X. Epub 2012 Aug 30. Erratum in: Lancet. 2012 Oct 20;380(9851):1386.

PMID:
22938757
7.

A comparative lipidomics platform for chemotaxonomic analysis of Mycobacterium tuberculosis.

Layre E, Sweet L, Hong S, Madigan CA, Desjardins D, Young DC, Cheng TY, Annand JW, Kim K, Shamputa IC, McConnell MJ, Debono CA, Behar SM, Minnaard AJ, Murray M, Barry CE 3rd, Matsunaga I, Moody DB.

Chem Biol. 2011 Dec 23;18(12):1537-49. doi: 10.1016/j.chembiol.2011.10.013.

8.

Improved rapid molecular diagnosis of multidrug-resistant tuberculosis using a new reverse hybridization assay, REBA MTB-MDR.

Bang H, Park S, Hwang J, Jin H, Cho E, Kim DY, Song T, Shamputa IC, Via LE, Barry CE 3rd, Cho SN, Lee H.

J Med Microbiol. 2011 Oct;60(Pt 10):1447-54. doi: 10.1099/jmm.0.032292-0. Epub 2011 May 19.

9.

Management of pulmonary tuberculosis patients in an urban setting in Zambia: a patient's perspective.

Mulenga C, Mwakazanga D, Vereecken K, Khondowe S, Kapata N, Shamputa IC, Meulemans H, Rigouts L.

BMC Public Health. 2010 Dec 7;10:756. doi: 10.1186/1471-2458-10-756.

10.

Diversity of Mycobacterium tuberculosis genotypes circulating in Ndola, Zambia.

Mulenga C, Shamputa IC, Mwakazanga D, Kapata N, Portaels F, Rigouts L.

BMC Infect Dis. 2010 Jun 17;10:177. doi: 10.1186/1471-2334-10-177.

11.

Low Occurrence of Tuberculosis Drug Resistance among Pulmonary Tuberculosis Patients from an Urban Setting, with a Long-Running DOTS Program in Zambia.

Mulenga C, Chonde A, Bwalya IC, Kapata N, Kakungu-Simpungwe M, Docx S, Fissette K, Shamputa IC, Portaels F, Rigouts L.

Tuberc Res Treat. 2010;2010:938178. doi: 10.1155/2010/938178. Epub 2010 Jun 30.

12.

Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean Patients with drug-resistant tuberculosis.

Via LE, Cho SN, Hwang S, Bang H, Park SK, Kang HS, Jeon D, Min SY, Oh T, Kim Y, Kim YM, Rajan V, Wong SY, Shamputa IC, Carroll M, Goldfeder L, Lee SA, Holland SM, Eum S, Lee H, Barry CE 3rd.

J Clin Microbiol. 2010 Feb;48(2):402-11. doi: 10.1128/JCM.01476-09. Epub 2009 Dec 23.

13.

Genetic diversity of Mycobacterium tuberculosis isolates from a tertiary care tuberculosis hospital in South Korea.

Shamputa IC, Lee J, Allix-Béguec C, Cho EJ, Lee JI, Rajan V, Lee EG, Min JH, Carroll MW, Goldfeder LC, Kim JH, Kang HS, Hwang S, Eum SY, Park SK, Lee H, Supply P, Cho SN, Via LE, Barry CE 3rd.

J Clin Microbiol. 2010 Feb;48(2):387-94. doi: 10.1128/JCM.02167-09. Epub 2009 Dec 16.

14.

Possible outbreak of streptomycin-resistant Mycobacterium tuberculosis Beijing in Benin.

Affolabi D, Faïhun F, Sanoussi N, Anyo G, Shamputa IC, Rigouts L, Kestens L, Anagonou S, Portaels F.

Emerg Infect Dis. 2009 Jul;15(7):1123-5. doi: 10.3201/eid1507.080697.

15.

Isolation and characterization of Mycobacterium bovis strains from indigenous Zambian cattle using Spacer oligonucleotide typing technique.

Munyeme M, Rigouts L, Shamputa IC, Muma JB, Tryland M, Skjerve E, Djønne B.

BMC Microbiol. 2009 Jul 20;9:144. doi: 10.1186/1471-2180-9-144.

16.

Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii.

Zelazny AM, Root JM, Shea YR, Colombo RE, Shamputa IC, Stock F, Conlan S, McNulty S, Brown-Elliott BA, Wallace RJ Jr, Olivier KN, Holland SM, Sampaio EP.

J Clin Microbiol. 2009 Jul;47(7):1985-95. doi: 10.1128/JCM.01688-08. Epub 2009 May 6.

17.

First molecular epidemiological study of tuberculosis in Benin.

Affolabi D, Anyo G, Faïhun F, Sanoussi N, Shamputa IC, Rigouts L, Kestens L, Anagonou S, Portaels F.

Int J Tuberc Lung Dis. 2009 Mar;13(3):317-22.

PMID:
19275790
18.

High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia.

Jugheli L, Rigouts L, Shamputa IC, Bram de Rijk W, Portaels F.

Int J Tuberc Lung Dis. 2008 May;12(5):561-6.

PMID:
18419893
19.

Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.

Umubyeyi A, Rigouts L, Shamputa IC, Dediste A, Struelens M, Portaels F.

Int J Infect Dis. 2008 Mar;12(2):152-6. Epub 2007 Oct 18.

20.

Molecular investigation of recurrent tuberculosis in patients from Rwanda.

Umubyeyi AN, Shamputa IC, Rigouts L, Dediste A, Karita E, Struelens MJ, Portaels F.

Int J Tuberc Lung Dis. 2007 Aug;11(8):860-7.

PMID:
17705951
21.

Endogenous reactivation and true treatment failure as causes of recurrent tuberculosis in a high incidence setting with a low HIV infection.

Shamputa IC, Van Deun A, Salim MA, Hossain MA, Fissette K, de Rijk P, Rigouts L, Portaels F.

Trop Med Int Health. 2007 Jun;12(6):700-8.

22.

Evidence of 'amplifier effect' in pulmonary multidrug-resistant tuberculosis: report of three cases.

Umubyeyi A, Shamputa IC, Rigouts L, Dediste A, Struelens M, Portaels F.

Int J Infect Dis. 2007 Nov;11(6):508-12. Epub 2007 Mar 21.

23.

Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey.

Umubyeyi AN, Rigouts L, Shamputa IC, Fissette K, Elkrim Y, de Rijk PW, Struelens MJ, Portaels F.

J Antimicrob Chemother. 2007 May;59(5):1031-3. Epub 2007 Feb 28.

PMID:
17329272
24.

Direct detection of Mycobacterium tuberculosis complex DNA and rifampin resistance in clinical specimens from tuberculosis patients by line probe assay.

Traore H, van Deun A, Shamputa IC, Rigouts L, Portaels F.

J Clin Microbiol. 2006 Dec;44(12):4384-8. Epub 2006 Oct 11.

25.

Mixed infection and clonal representativeness of a single sputum sample in tuberculosis patients from a penitentiary hospital in Georgia.

Shamputa IC, Jugheli L, Sadradze N, Willery E, Portaels F, Supply P, Rigouts L.

Respir Res. 2006 Jul 17;7:99.

26.

Molecular genetic methods for diagnosis and antibiotic resistance detection of mycobacteria from clinical specimens.

Shamputa IC, Rigouts And L, Portaels F.

APMIS. 2004 Nov-Dec;112(11-12):728-52. Review.

PMID:
15638836
27.

Genotypic and phenotypic heterogeneity among Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients.

Shamputa IC, Rigouts L, Eyongeta LA, El Aila NA, van Deun A, Salim AH, Willery E, Locht C, Supply P, Portaels F.

J Clin Microbiol. 2004 Dec;42(12):5528-36. Erratum in: J Clin Microbiol. 2005 Feb;43(2):1015.

28.

Treatment of multidrug-resistant tuberculosis.

Colebunders R, Apers L, Shamputa IC.

Lancet. 2004 Apr 10;363(9416):1240. No abstract available.

PMID:
15081672
29.

PCR-based genotyping of Mycobacterium tuberculosis with new GC-rich repeated sequences and IS6110 inverted repeats used as primers.

Kotłowski R, Shamputa IC, El Aila NA, Sajduda A, Rigouts L, van Deun A, Portaels F.

J Clin Microbiol. 2004 Jan;42(1):372-7.

30.

Detection of phospholipase C in nontuberculous mycobacteria and its possible role in hemolytic activity.

Gomez A, Mve-Obiang A, Vray B, Rudnicka W, Shamputa IC, Portaels F, Meyers WM, Fonteyne PA, Realini L.

J Clin Microbiol. 2001 Apr;39(4):1396-401.

Supplemental Content

Loading ...
Support Center